Trima Accel
Payments companies reported to CMS as associated with Trima Accel. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Trima Accel, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Trima Accel
These are the largest totals companies reported as associated with Trima Accel. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ira Davis | Cleveland, OH | Pediatric Nephrology | $101,243.75 |
| Amber Sanchez | San Diego, CA | Nephrology (Internal Medicine) | $5,668.13 |
| Miguel Abboud | Charleston, SC | Pediatric Hematology-Oncology | $5,530.00 |
| Charles Knudson | Iowa City, IA | Blood Banking & Transfusion Medicine | $4,510.00 |
| Bhupendra Khatri | Milwaukee, WI | Neurology (Psychiatry & Neurology) | $4,000.00 |
| Mark Yazer | Pittsburgh, PA | $1,725.00 | |
| John Manis | Boston, MA | Hematology & Oncology | $1,200.00 |
| Tina Ipe | Little Rock, AR | Clinical Pathology/Laboratory Medicine | $285.17 |
| Barbara Bryant | Milwaukee, WI | Blood Banking & Transfusion Medicine | $149.66 |
| Ralph Vassallo | Philadelphia, PA | Hematology (Internal Medicine) | $148.88 |
Prescribed Trima Accel?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.